Muscadine Grape Skin Extract in Biochemically Recurrent PCa.

[pjoshea13]

New study below [1].

Odd to see so many Johns Hopkins names among to 23 co-authors, considering the topic.

"Compared with placebo, MPX did not significantly prolong PSADT in BCR patients over two different doses. Exploratory analysis revealed a patient population with potential benefit that would require further study."

"In a preplanned exploratory analysis, PSADT pre-to-post increase was significant in the 27 (26%) genotyped patients with SOD2 Alanine/Alanine genotype (rs4880 T>C polymorphism) on MPX (pooled treatment arms) (6.4 months ...), but not in control (1.8 months ...)"

-Patrick

[1] clincancerres.aacrjournals....